This broader expression pattern is consistent with previous studies reporting that RIBC2 and MCM3AP-AS1 are differentially expressed and clinically relevant in various human cancers beyond colon cancer, likely through mechanisms independent of m6A regulation50–52. Here, MCM3AP is linked to colonic neoplasm.